FloridaMarijuana.net

AUGUST 15, 2018

Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Treatments also seek to increase the subject’s ability to manage trauma-related emotions and to greater confidence in coping abilities. The endocannabinoid system consists of cannabinoid receptors all over the body.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

JANUARY 12, 2021

IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was awarded… Read More.

Treatment 59

Treatment Cannabinoids Pharmaceutical Law 59

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In part of one of this series, we analyzed the discussions surrounding using cannabis for mental health. In part two, we took a deep look at using cannabis for depression. In part three, we will analyze the available research concerning cannabis and anxiety. Can you use cannabis for anxiety? Cannabis and Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

JULY 1, 2021

As Curaleaf International ‘s subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa , with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Treatment 93

Treatment Pharmaceutical Therapy Oil 93

Cannabis Law Report

APRIL 22, 2021

Patent protects Supera-CBD, a preclinical cannabidiol derivative that targets cannabinoid receptor type 2 for the treatment of neuroinflammatory and neurodegenerative… Read More.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment CBD 98

Veriheal

AUGUST 31, 2020

Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. Participants in the study used an application called “Releaf Application” in order to record the details of their cannabis use.

Treatment 98

Treatment Consumption Indica Hybrid 98

Veriheal

JANUARY 26, 2023

According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar disorder. In this article, we’ll explore how the potential advantages of cannabis might help stabilize symptoms associated with bipolar disorder. Most commonly, pharmaceutical medication is prescribed to regulate moods.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Since the popularization of CBD in recent years, it’s more common to see cannabis recognized as a true medical treatment. However, CBD and the psychoactive THC aren’t the only compounds found in the cannabis plant. Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. What Is CBN? How Is CBN Created?

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). In addition to this, the survey results featured responses from 138 patients who did not use any type of cannabis product.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

WeedAdvisor

JANUARY 8, 2019

For decades, marijuana for cancer treatment seemed out of the question. Even if trials were successful, it is safe to say that using marijuana to treat cancer would meet resistance from the pharmaceutical companies and medical communities alike. But with countries like Canada and Uruguay have legalized cannabis entirely, and the U.S.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. Cannabis has been shown in several studies to successfully treat seizures , completely eradicating them in some cases. CONVENTIONAL TREATMENT. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

United Patients Group

FEBRUARY 7, 2023

Benefits of Cannabis for Inflammation and Pain Introduction Inflammation and pain are two of the most common health issues that many people face. Cannabis has been used as medicine for thousands of years, and there are many different ways this plant can help with inflammation and pain relief by interacting with our bodies in different ways.

Cannabinoids 114

Cannabinoids Chronic Pain Terpenes THC 114

Canna Care Docs

OCTOBER 3, 2023

Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Veriheal

APRIL 7, 2022

Now, a new study has found that medical marijuana (MMJ) shows promise as a treatment for MS. . While cannabis’ potential to assist with MS has been known for some time now, it’s important to bolster previous findings with expansive research. The Need for Better MS Treatment. The Need for Better MS Treatment.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Cannabis Law Report

SEPTEMBER 28, 2021

Acupuncture is one of the safest alternative forms of treatment for chronic pain. Ideally, it should be used in combination with other therapies, such as herbal medicine and massage, and can be a great addition to other treatments. Radio Frequency Treatment. Acupuncture. First, you need to find a certified acupuncturist.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

SpeedWeed

AUGUST 8, 2021

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . “It’s not just street cannabis put into a bottle,” GW Pharmaceutical CEO Justin Gover once told the Guardian. View original article.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

Cannabis Law Report

AUGUST 12, 2022

. – August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

Extraction 52

Extraction Pharmaceutical Patients THC 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Medical cannabis costs family £4,000 a month to help teenager. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Cannabis for GI Pathologies . What is IBD? Doesn’t lead to permanent damages. . Risk factor for colon cancer. .

Digestion 123

Digestion Treatment Conditions Research and Development 123

PrestoDoctor

DECEMBER 12, 2023

The Use of Cannabis Among Seniors More and more seniors are turning to cannabis as an alternative to traditional medications. As the stigma surrounding cannabis use decreases and more research shows the potential benefits, older adults are exploring this natural remedy for various ailments.

Medicine 98

Medicine Chronic Pain Consumption Pharmaceutical 98

Cannabis Law Report

DECEMBER 14, 2021

Pharmaceutical giant Pfizer Inc. is entering the cannabis space via the $6.7 billion acquisition of Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, based in San Diego, Cal., is a biotech company with one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Read more at.

Research and Development 52

Research and Development Pharmaceutical Therapy Treatment 52

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105

The Cannigma

NOVEMBER 16, 2022

Can cannabis reduce acid reflux and heartburn? 6 medicinal plants that pharmaceuticals can't replace. At this point, there simply isn’t much research on cannabis use to combat acid reflux and GERD. Cannabis and acid reflux: the research. How might cannabis be able to help with acid reflux? Related Stories.

Digestion 119

Digestion Cannabinoids Pharmaceutical THC 119

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. Anti-seizure Properties.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Presently, CBD is inarguably the most acceptable compound in cannabis. Some have even explored it for its aphrodisiac potential.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

JANUARY 16, 2022

The government will review the Dangerous Drugs Act 1952 and the Poisons Act 1952 to regulate cannabis and ketum for medical use, Health Minister Khairy Jamaluddin said. Cannabis, or marijuana, is currently banned under the Dangerous Drugs Act that imposes extremely harsh penalties for the use of illegal narcotics.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

SpeedWeed

JULY 29, 2021

Why do you consume cannabis? In addition to THC and CBD, hemp and cannabis contain dozens of other cannabinoids that can aid everything from appetite suppression and weight loss to fighting insomnia or inflammation. Cannabis and weight loss don’t usually roll off the tongue together. THCV for Energy and Weight Loss.

Sleep 52

Sleep Cannabinoids Oil THC 52

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

United Patients Group

APRIL 18, 2023

Introduction The medical cannabis industry is booming. However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. Myth: Cannabis is just a drug. Cannabis is a plant. Myth: Cannabis is a gateway to other drugs. Myth: Cannabis is a cure-all.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. The society launched a campaign with the hashtag #ApprovedButDenied protesting the difficulty so many patients have faced attempting to obtain medical cannabis. ApprovedButDenied.

Treatment 98

Treatment Patients Access Research and Development 98

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. The active compounds in marijuana, known as cannabinoids, interact with the body’s endocannabinoid system to produce therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

Cannabis Law Report

NOVEMBER 22, 2019

The company received a patent from the US Patent and Trademark Office, its sixth from the agency, pertaining to its proprietary chilled cannabinoid extraction process with downstream media treatment and filtration. READ: Nextleaf Solutions says its distillation plant on pace to be completed by end of this month. ” .

Extraction 59

Extraction Cannabinoids Oil Pharmaceutical 59